Literature DB >> 16443002

Relationships among tumor burden, tumor size, and the changing concentrations of fibrin degradation products and fibrinolytic factors in the pleural effusions of rabbits with VX2 lung tumors.

Mark W C Hatton1, Suzanne M R Southward, Bonnie L Ross, Bryan J Clarke, Gurmit Singh, Mary Richardson.   

Abstract

The VX2 tumor is derived from a papilloma virus-induced rabbit epithelial cell line. If VX2 tumor cells (trapped in a plasma clot) are introduced intravenously into NZW rabbits, the cells lodge in the lung capillary bed and produce tumors. Independently of the tumor burden (ie, the total tumor weight per rabbit), approximately 15% of rabbits with VX2 lung tumors accumulate an effusion in the interpleural space and this pleural effusion contains products of hemostasis. We hypothesized that these products were of intra-tumoral origin and that they changed in concentration as tumor burden increased. Interrelationships among lung-, tumor-weights, and pleural effusion volumes, and the concentrations of fibrinolytic factors, their catabolic products, and other proteins of pleural effusions were measured in rabbits with a wide range of tumor burdens. Positive correlations between tumor burden and total lung weight and between pleural effusion volume and net lung weight suggested that interstitial fluid from the stroma of tumors passed directly into the extravascular space of the lung(s) and into the interpleural space(s). Analyses of pleural effusions indicated that plasminogen-, alpha(2)-antiplasmin-, and plasminogen activator inhibitor-1-related proteins, urokinase-like- and tissue-plasminogen activator activities, and vascular endothelial growth factor increased in concentration up to a tumor burden of approximately 20-25 g. Plasmin activity and intact fibrinogen were absent. The concentration of fibrin(ogen) degradation products did not change significantly up to a tumor burden of approximately 25 g but increased substantially as tumor burdens exceeded 25 g. In conclusion, interstitial fluid from tumors enters the extravascular space of the host and may accumulate with fluid from non-tumor sources as a pleural effusion. The concentrations of fibrinolytic factors and their products in pleural effusions reflect the tumor burden of the rabbit. Conceivably, the components of a malignant effusion contain much information about the extent of tumor growth.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16443002     DOI: 10.1016/j.lab.2005.08.014

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  6 in total

1.  Establishment of a malignant pleural effusion mouse model: pathogenesis pathways.

Authors:  Kalliopi Domvri; Paul Zarogoulidis; Fotis Theodoropoulos; Haidong Huang; Konstantinos Zarogoulidis
Journal:  Transl Lung Cancer Res       Date:  2012-09

2.  Plasmin enhances cell surface tissue factor activity in mesothelial and endothelial cells.

Authors:  H Kothari; G Kaur; S Sahoo; S Idell; L V M Rao; U Pendurthi
Journal:  J Thromb Haemost       Date:  2008-11-03       Impact factor: 5.824

3.  Advantages of the AMDL-ELISA DR-70 (FDP) assay over carcinoembryonic antigen (CEA) for monitoring colorectal cancer patients.

Authors:  Andrea L Small-Howard; Holden Harris
Journal:  J Immunoassay Immunochem       Date:  2010

4.  Novel distribution pattern of fibrinolytic components in rabbit tissues extract: a preliminary study.

Authors:  Xing-guo Lu; Xian-guo Wu; Xiao-hua Xu; Xu-bo Gong; Xuan Zhou; Gen-bo Xu; Lei Zhu; Xiao-ying Zhao
Journal:  J Zhejiang Univ Sci B       Date:  2007-08       Impact factor: 3.066

5.  Role of DR-70 immunoassay in suspected malignant pleural effusion.

Authors:  Amitabha Sengupta; Kaushik Saha; Debraj Jash; Sourindra Nath Banerjee; Nirendra Mohan Biswas; Atin Dey
Journal:  Lung India       Date:  2013-10

6.  Biomarkers for screening of lung cancer and pre-neoplastic lesions in a high risk Chilean population.

Authors:  Marta I Adonis; Jose Díaz; Veronica R Miranda; Marco Chahuan; Alcides Zambrano; Hugo C Benitez; Monica Campos; Pablo Avaria; Ulises Urzúa; Pedro Marín; Mariela Gohurdett; Yasna Cisterna; Lionel Gil
Journal:  Biol Res       Date:  2014-11-25       Impact factor: 5.612

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.